Ah, Sarge, but its not their fault, you see, they are in the...

First 6 Last

Share
Profile

Follow
joohnno

2,396 Posts.

628

08/12/23

14:01

Post #: 71348842
Share

Originally posted by sarge17 ↑

Remembering when we were looking forward to SPL releasing the DEP-Docetaxel results in 2018. No.

Then 2019. No.
Then 2020. No.
Then 2021. No.
Then 2022. No.

Then, finally some hardened timelines:

Quarterly 26/10/22:
Mono to complete recruitment next 2-3 months (end of Jan23). No missed this one.

Quarterly 30/1/23:
Mono now expected to complete recruitment in the next month. (end of Feb23).

Quarterly 28/4/23:
Mono and avail combo data expected by end of Sep 23. Nope. Missed this latest target too.

Quarterly 31/7/23:
Still expecting top-line results by end of September (only 30 days away.) Big nope again, even missing that 30 day deadline)

Quartely 31/10/23:
Goal posts moved yet again. Now apparently mono and combo results expected to be released by end of Dec.

Can Starpharma finally hit the dart board when they are literally 2 feet away from it? Gee I hope so, but would not be surprised at all if they somehow miss.

Expand

Ah, Sarge, but its not their fault, you see, they are in the hands of the trial managers.

But who appointed these "managers" . the same ones which appointed the worst international distributor of women's heath care on the planet.

That is why SPL management has to go! At least the person or persons responsible for these decisions.

SPL Price at posting: 13.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

1 Great analysis

Reply